Cargando…

Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan

BACKGROUND: Induction of labour (IOL) is an important and common clinical procedure in obstetrics. In the current study, we evaluate predictors of vaginal delivery in both nulliparous and multiparous women in north Jordan who were induced with vaginal prostaglandins. METHOD: A prospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Obeidat, Rawan A., Almaaitah, Mahmoud, Ben-Sadon, Abeer, Istaiti, Dina, Rawashdeh, Hasan, Hamadneh, Shereen, Hammouri, Hanan, Bataineh, Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496008/
https://www.ncbi.nlm.nih.gov/pubmed/34620120
http://dx.doi.org/10.1186/s12884-021-04151-3
_version_ 1784579669993979904
author Obeidat, Rawan A.
Almaaitah, Mahmoud
Ben-Sadon, Abeer
Istaiti, Dina
Rawashdeh, Hasan
Hamadneh, Shereen
Hammouri, Hanan
Bataineh, Adel
author_facet Obeidat, Rawan A.
Almaaitah, Mahmoud
Ben-Sadon, Abeer
Istaiti, Dina
Rawashdeh, Hasan
Hamadneh, Shereen
Hammouri, Hanan
Bataineh, Adel
author_sort Obeidat, Rawan A.
collection PubMed
description BACKGROUND: Induction of labour (IOL) is an important and common clinical procedure in obstetrics. In the current study, we evaluate predictors of vaginal delivery in both nulliparous and multiparous women in north Jordan who were induced with vaginal prostaglandins. METHOD: A prospective study was conducted on 530 pregnant women at King Abdullah University Hospital (KAUH) in north Jordan. All pregnant mothers with singleton live fetuses, who had induction of labour (IOL) between July 2017 and June 2019, were included in the study. Mode of delivery, whether vaginal or caesarean, was the primary outcome. Several maternal and fetal variables were investigated. The safety and benefit of repeated dosage of vaginal prostaglandin E2 (PGE2) tablets, neonatal outcomes and factors that affect duration of labour were also evaluated. Pearson χ2 test was used to investigate the significance of association between categorical variables, while student’s t-test and ANOVA were applied to examine the mean differences between categorical and numerical variables. Linear regression analysis was utilized to study the relation between two continuous variables. A multivariate regression analysis was then performed. Significance level was considered at alpha less than 0.05. RESULTS: Nulliparous women (N = 254) had significantly higher cesarean delivery rate (58.7% vs. 17.8%, p < 0.001) and longer duration of labour (16.1 ± 0.74 h vs. 11.0 ± 0.43 h, p < 0.001) than multiparous women (N = 276). In nulliparous women, the rate of vaginal delivery was significantly higher in women with higher Bishop score; the mean Bishop score was 3.47 ± 0.12 in nulliparous women who had vaginal delivery vs. 3.06 ± 0.10 in women who had cesarean delivery (Adjusted odds ratio (AOR) = 1.2, 95% CI: 1.03–1.28, p = 0.03). In multiparous women, the rate of vaginal delivery was significantly higher in women with higher Bishop scores and lower in women with higher body mass index (BMI). The mean Bishop score was 3.97 ± 0.07 in multiparous women who had vaginal delivery vs. 3.56 ± 0.16 in women who had cesarean delivery (AOR = 1.5, 95% CI: 1.1–2.1, p = 0.01). The mean BMI was 30.24 ± 0.28 kg/m(2) in multiparous women who had vaginal delivery vs. 32.36 ± 0.73 kg/m(2) in women who had cesarean delivery (AOR = 0.89, 95% CI: 0.84–0.96, p = 0.005). 27% of nulliparous women who received more than two PGE2 tablets and 50% of multiparous women who received more than two PGE2 tablets had vaginal delivery with no significant increase in neonatal morbidity. CONCLUSION: Parity and cervical status are the main predictors of successful labour induction. Further studies are required to investigate the benefit of the use of additional doses of vaginal PGE2 above the recommended dose for IOL.
format Online
Article
Text
id pubmed-8496008
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84960082021-10-07 Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan Obeidat, Rawan A. Almaaitah, Mahmoud Ben-Sadon, Abeer Istaiti, Dina Rawashdeh, Hasan Hamadneh, Shereen Hammouri, Hanan Bataineh, Adel BMC Pregnancy Childbirth Research BACKGROUND: Induction of labour (IOL) is an important and common clinical procedure in obstetrics. In the current study, we evaluate predictors of vaginal delivery in both nulliparous and multiparous women in north Jordan who were induced with vaginal prostaglandins. METHOD: A prospective study was conducted on 530 pregnant women at King Abdullah University Hospital (KAUH) in north Jordan. All pregnant mothers with singleton live fetuses, who had induction of labour (IOL) between July 2017 and June 2019, were included in the study. Mode of delivery, whether vaginal or caesarean, was the primary outcome. Several maternal and fetal variables were investigated. The safety and benefit of repeated dosage of vaginal prostaglandin E2 (PGE2) tablets, neonatal outcomes and factors that affect duration of labour were also evaluated. Pearson χ2 test was used to investigate the significance of association between categorical variables, while student’s t-test and ANOVA were applied to examine the mean differences between categorical and numerical variables. Linear regression analysis was utilized to study the relation between two continuous variables. A multivariate regression analysis was then performed. Significance level was considered at alpha less than 0.05. RESULTS: Nulliparous women (N = 254) had significantly higher cesarean delivery rate (58.7% vs. 17.8%, p < 0.001) and longer duration of labour (16.1 ± 0.74 h vs. 11.0 ± 0.43 h, p < 0.001) than multiparous women (N = 276). In nulliparous women, the rate of vaginal delivery was significantly higher in women with higher Bishop score; the mean Bishop score was 3.47 ± 0.12 in nulliparous women who had vaginal delivery vs. 3.06 ± 0.10 in women who had cesarean delivery (Adjusted odds ratio (AOR) = 1.2, 95% CI: 1.03–1.28, p = 0.03). In multiparous women, the rate of vaginal delivery was significantly higher in women with higher Bishop scores and lower in women with higher body mass index (BMI). The mean Bishop score was 3.97 ± 0.07 in multiparous women who had vaginal delivery vs. 3.56 ± 0.16 in women who had cesarean delivery (AOR = 1.5, 95% CI: 1.1–2.1, p = 0.01). The mean BMI was 30.24 ± 0.28 kg/m(2) in multiparous women who had vaginal delivery vs. 32.36 ± 0.73 kg/m(2) in women who had cesarean delivery (AOR = 0.89, 95% CI: 0.84–0.96, p = 0.005). 27% of nulliparous women who received more than two PGE2 tablets and 50% of multiparous women who received more than two PGE2 tablets had vaginal delivery with no significant increase in neonatal morbidity. CONCLUSION: Parity and cervical status are the main predictors of successful labour induction. Further studies are required to investigate the benefit of the use of additional doses of vaginal PGE2 above the recommended dose for IOL. BioMed Central 2021-10-07 /pmc/articles/PMC8496008/ /pubmed/34620120 http://dx.doi.org/10.1186/s12884-021-04151-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Obeidat, Rawan A.
Almaaitah, Mahmoud
Ben-Sadon, Abeer
Istaiti, Dina
Rawashdeh, Hasan
Hamadneh, Shereen
Hammouri, Hanan
Bataineh, Adel
Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title_full Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title_fullStr Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title_full_unstemmed Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title_short Clinical predictive factors for vaginal delivery following induction of labour among pregnant women in Jordan
title_sort clinical predictive factors for vaginal delivery following induction of labour among pregnant women in jordan
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496008/
https://www.ncbi.nlm.nih.gov/pubmed/34620120
http://dx.doi.org/10.1186/s12884-021-04151-3
work_keys_str_mv AT obeidatrawana clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT almaaitahmahmoud clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT bensadonabeer clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT istaitidina clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT rawashdehhasan clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT hamadnehshereen clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT hammourihanan clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan
AT batainehadel clinicalpredictivefactorsforvaginaldeliveryfollowinginductionoflabouramongpregnantwomeninjordan